CD79A-CHIMÄRE ANTIGENREZEPTOREN
Patent europeic · EP3806903 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP3806903
- Numer da la dumonda
- EP19819809
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 14-06-2019
- Publitgà
- 21-04-2021
- Concedì
- 14-02-2024
- La protecziun finescha il pli tard
- 13-06-2039
- Proxima taxa annuala scadenta
- 30-06-2027
- Classas IPC
- A61K 39/395 (2006.01)A61K 39/44 (2006.01)C07K 16/28 (2006.01)C07K 16/30 (2006.01)C07K 14/705 (2006.01)
- Prioritad
- US 201862685078 P 14.06.2018
- Dumonda PCT
- PCT/US2019/037270 14.06.2019
- Publicaziun PCT
- WO2019/241685 19.12.2019
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-07-2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
- 01-07-2025
Next annual fee due on
- Next annual fee due on
- 30.06.2025 → 30.06.2026
Published in Swissreg on 01.07.2025
- 22-01-2025
Transferì
- Owner
- 2seventy bio, Inc., 60 Binney Street, Cambridge, MA 02142, USA → Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA
Published in Swissreg on 22.01.2025
- 25-12-2024
Midada
Published in Swissreg on 25.12.2024
- 01-07-2024
Midada
Published in Swissreg on 01.07.2024
- 20-03-2024
Represchentant inscrit
- Representative
- Murgitroyd & Company, Geneva Rhone 8 Sàrl, Rue du Commerce 4, 1204 Genève
Published in Swissreg on 20.03.2024
- 14-02-2024
Concedì
Published in Swissreg on 14.02.2024
Partidas
Inventur
Melrose, Massachusetts 02176, US
Milton, Massachusetts 02186, US
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.